Answer
Interactions between eptinezumab and medicines that are substrates, inducers or inhibitors of cytochrome P450 enzymes are considered unlikely because eptinezumab is not metabolized by these enzymes.
Sources for this answer
- Vyepti 100 mg concentrate for solution for infusion (300 mg not marketed)Lundbeck Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 4Document updated
Sources checked